| Sumario: | Rollout of antiretroviral (ARV) therapy under the aegis of the WHO’s “3 by 5” initiative, with funding from numerous donors via the Global Fund for TB, HIV/ AIDS, and malaria, the U.S. PEPFAR and U.K. DFID, gives cause for hope for all those millions of people in Africa who are living with HIV/AIDS. Midway through 2005 nobody seriously believed that the target of 3 million people on treatment by year end would be achieved. However, it was a necessary goal at that stage. But for those concerned with meeting the challenge of HIV/AIDS impacts, increased antiretroviral therapy (ART) availability has to be seen for what it is: an opportunity to take a breath in the struggle against the impact of AIDS and think, and think hard, about what we do next.
|
|---|